SCHEMBL9997384

SCHEMBL9997384

COc1ccc(S(=O)(=O)Nc2cccc(C(=O)O)c2O)cc1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
KEAP1 Q14145 1/20 0.57
NFE2L2 Q16236 1/20 0.57
CA12 O43570 1/20 0.56
CA9 Q16790 1/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
GAA P10253 2/20 0.56
ALDH1A1 P00352 6/20 0.55
KDM4E B2RXH2 4/20 0.55
HSD17B10 Q99714 1/20 0.55
PGAM1 P18669 1/20 0.55
POLB P06746 1/20 0.53
TP53 P04637 1/20 0.53
CYP2C9 P11712 1/20 0.53
HTT P42858 1/20 0.52
MAPT P10636 1/20 0.52
WDR5 P61964 1/20 0.52
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28784798 0.89 LMNA (0.68) LMNASMN1; SMN2KEAP1NFE2L2CA12
SCHEMBL9997531 0.88 KMT2A (0.66) LMNASMN1; SMN2MEN1KMT2AGAA
SCHEMBL3561138 0.81 SMN1; SMN2 (0.59) LMNASMN1; SMN2KEAP1NFE2L2CA12
SCHEMBL9997386 0.81 ALDH1A1 (0.62) LMNAMEN1KMT2AGAAALDH1A1
SCHEMBL9997964 0.81 FABP4 (0.60) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3560739 0.80 SMN1; SMN2 (0.57) LMNASMN1; SMN2KEAP1NFE2L2CA12
SCHEMBL3559521 0.79 SMN1; SMN2 (0.56) LMNASMN1; SMN2KEAP1NFE2L2CA12
SCHEMBL28637555 0.79 KMT2A (0.58) MEN1KMT2AGAAALDH1A1KDM4E
SCHEMBL9996881 0.79 ALDH1A1 (0.62) LMNASMN1; SMN2MEN1KMT2AGAA
SCHEMBL9997084 0.77 LMNA (0.68) LMNASMN1; SMN2CA12CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161201-A1 BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2011-12-29 WO disclosed